EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways

Ellis G Jaffray iD, Michael H Tatham iD, Barbara Mojsa iD, Anna Plechanovová iD, Alejandro Rojas-Fernandez iD, Julio C Y Liu iD, Niels Mailand iD, Adel F M Ibrahim iD, Graeme Ball iD, Iain M Porter iD, Ronald T Hay iD

Journal of Cell Biology · 02.06.2025 · 224 (6)

DOI: 10.1083/jcb.202407133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Biology, online erschienen am 16.04.2025. Verfasst von Ellis G Jaffray und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Promyelocytic Leukemia Protein, SUMO-1 Protein, Small Ubiquitin-Related Modifier Proteins, Nuclear Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, University of Dundee, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arsenic effectively treats acute promyelocytic leukemia by inducing SUMO and ubiquitin-dependent degradation of the promyelocytic leukemia (PML)–retinoic acid receptor alpha oncogenic fusion protein. However, some patients relapse with arsenic-resistant disease because of missense mutations in PML. To determine the mechanistic basis for arsenic resistance, PML−/− cells were reconstituted with YFP fusions of wild-type PML-V and two common patient mutants: A216T and L217F. Both mutants were resistant to degradation by arsenic but for different biochemical reasons. Arsenic did not trigger SUMOylation of A216T PML, which failed to recruit the SUMO-targeting ubiquitin ligases RNF4 and TOPORS. L217F PML did respond with increased SUMO2/3 conjugation that facilitated RNF4 engagement but failed to reach the threshold of SUMO1 conjugation required to recruit TOPORS. Thus, neither mutant accumulated the appropriate polyubiquitin signal required for p97 binding. These PML mutants have revealed a convergence of SUMO1, SUMO2/3, TOPORS, and RNF4 that facilitates the arsenic-induced degradation of PML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Promyelocytic Leukemia ProteinSUMO-1 ProteinSmall Ubiquitin-Related Modifier ProteinsNuclear ProteinsLeukemia, Promyelocytic, AcuteDrug Resistance, NeoplasmTranscription FactorsArsenicHumansProteolysisSumoylationHEK293 CellsUbiquitin-Protein LigasesMutationUbiquitins

Substanzen

RNF4 protein, humanPromyelocytic Leukemia ProteinSUMO-1 ProteinSmall Ubiquitin-Related Modifier ProteinsNuclear ProteinsPML protein, humanSUMO2 protein, humanSUMO1 protein, humanSUMO3 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Division of Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK.
  • Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen , Copenhagen, Denmark.
  • Dundee Imaging Facility, School of Life Sciences, University of Dundee, Dundee, UK.

ORCID-Profile: Ellis G Jaffray, Michael H Tatham, Barbara Mojsa, Anna Plechanovová, Alejandro Rojas-Fernandez, Julio C Y Liu, Niels Mailand, Adel F M Ibrahim, Graeme Ball, Iain M Porter, Ronald T Hay

Förderung

  • Novo Nordisk Fonden
  • University of Dundee
  • Cancer Research UK
  • Wellcome Trust

Zitieren

APA

Jaffray, E. G., Tatham, M. H., Mojsa, B., Plechanovová, A., Rojas-Fernandez, A., Liu, J. C. Y., Mailand, N., Ibrahim, A. F. M., Ball, G., Porter, I. M., & Hay, R. T. (2025). PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways. Journal of Cell Biology, 224(6). https://doi.org/10.1083/jcb.202407133

Vancouver

Jaffray EG, Tatham MH, Mojsa B, Plechanovová A, Rojas-Fernandez A, Liu JCY, et al. PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways. Journal of Cell Biology. 2025;224(6). doi:10.1083/jcb.202407133

BibTeX
@article{Jaffray2025,
  author = {Jaffray, Ellis G and Tatham, Michael H and Mojsa, Barbara and Plechanovová, Anna and Rojas-Fernandez, Alejandro and Liu, Julio C Y and Mailand, Niels and Ibrahim, Adel F M and Ball, Graeme and Porter, Iain M and Hay, Ronald T},
  title = {PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways},
  journal = {Journal of Cell Biology},
  year = {2025},
  volume = {224},
  number = {6},
  doi = {10.1083/jcb.202407133}
}
Kostenlos starten →